Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 4/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4664060 | 0.71 | MGLL (0.40) | MGLLCA12CA7CA14CA1 | |
| SCHEMBL23312360 | 0.67 | MGLL (0.36) | MGLLCA12CA7CA14CA1 | |
| SCHEMBL8514284 | 0.67 | — | — | |
| SCHEMBL10599432 | 0.65 | MGLL (0.47) | MGLLCA12CA7CA14CA1 | |
| SCHEMBL236146 | 0.65 | MGLL (0.47) | MGLLCA12CA7CA14CA1 | |
| SCHEMBL8918333 | 0.64 | — | — | |
| SCHEMBL24440538 | 0.64 | TTR (0.43) | MGLLCA12CA7CA14CA1 | |
| SCHEMBL15854999 | 0.62 | ALDH1A1 (0.44) | MGLLCA12CA7CA14CA1 | |
| SCHEMBL7290045 | 0.62 | — | — | |
| SCHEMBL25928 | 0.62 | TTR (0.50) | MGLLCA12CA7CA14CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120329828-A1 | Cocaine Analogs and Methods of Preparation and Uses Thereof | NEW YORK UNIVERSITY (US) | 2012-12-27 | — | — | US | claimed |
| US-8557842-B2 | Cocaine analogs and methods of preparation and uses thereof | Temple University—Of the Commonwealth System of Higher Education (US) | 2013-10-15 | — | — | US | disclosed |
| US-20120329828-A1 | Cocaine Analogs and Methods of Preparation and Uses Thereof | NEW YORK UNIVERSITY (US) | 2012-12-27 | — | — | US | disclosed |
| WO-2012009263-A1 | COCAINE ANALOGS AND METHODS OF PREPARATION AND USES THEREOF | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329828-A1 | Cocaine Analogs and Methods of Preparation and Uses Thereof | CES2, CNR1, CNR2 | MGLL 3940/4885CA12 1823/4885CA7 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.